Economics of Treating Heart Failure
- 1 October 1997
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 80 (8) , 33H-38H
- https://doi.org/10.1016/s0002-9149(97)00818-7
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Use of angiotensin-converting enzyme inhibitors in heart failure with preserved left ventricular systolic functionAmerican Heart Journal, 1997
- The Effect of Digoxin on Mortality and Morbidity in Patients with Heart FailureNew England Journal of Medicine, 1997
- Analyses of cost effectiveness in the management of essential hypertension: What they can and what they do not teach usClinical Cardiology, 1996
- Does Increased Access to Primary Care Reduce Hospital Readmissions?New England Journal of Medicine, 1996
- Costs and effects of enalapril therapy in patients with symptomatic heart failure: An economic analysis of the studies of left ventricular dysfunction (SOLVD) treatment trialJournal of Cardiac Failure, 1995
- A Multidisciplinary Intervention to Prevent the Readmission of Elderly Patients with Congestive Heart FailureNew England Journal of Medicine, 1995
- Economic outcomes of withdrawal of digoxin therapy in adult patients with stable congestive heart failureJournal of the American College of Cardiology, 1995
- Costs and Effectiveness of Angiotensin Converting Enzyme Inhibition in Patients With Congestive Heart FailureArchives of internal medicine (1960), 1994
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991